Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 15, 2019

SELL
$97.32 - $148.76 $90,021 - $137,603
-925 Closed
0 $0
Q1 2018

Nov 09, 2018

BUY
$54.02 - $82.27 $49,968 - $76,099
925 New
925 $69,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $11.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Oak Grove Capital LLC Portfolio

Follow Oak Grove Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Grove Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Grove Capital LLC with notifications on news.